Long noncoding RNA DANCR in various cancers: a meta-analysis and bioinformatics

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Stewart BW,Wild CP.The global and regional burden of cancer.In: World cancer report 2014. World Health Organization; 2015;16–54.
   Google Scholar
• Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene. 2006;25(27):3866–3884. doi:10.1038/sj.onc.120955016799628
   PubMed Web of Science ®Google Scholar
• Desantis CE, Lin CC, Mariotto AB, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–271. doi:10.3322/caac.2123524890451
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136(4):629–641. doi:10.1016/j.cell.2009.02.00619239885
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155–159. doi:10.1038/nrg252119188922
   PubMed Web of Science ®Google Scholar
• Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(Spec No. 1):R17–R29. doi:10.1093/hmg/ddl04616651366
   PubMed Web of Science ®Google Scholar
• Poliseno L, Salmena L, Zhang J, et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 2010;465(7301):1033–1038. doi:10.1038/nature0914420577206
   PubMed Web of Science ®Google Scholar
• Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res. 2011;21(11):1944–1954. doi:10.1101/gr.122358.11121844124
   PubMed Web of Science ®Google Scholar
• Li T, Xie J, Shen C, et al. Amplification of long non-coding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma. Cancer Res. 2015;75(15):3181–3191. doi:10.1158/0008-5472.CAN-14-356926069248
   PubMed Web of Science ®Google Scholar
• Yang X, Xie X, Xiao YF, et al. The emergence of long non-coding RNAs in the tumorigenesis of hepatocellular carcinoma. Cancer Lett. 2015;360(2):119–124.11. doi:10.1016/j.canlet.2015.02.03525721084
   PubMed Web of Science ®Google Scholar
• Liang C, Liu J, Ge H, Xu Y, Li G, Wu J. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: a meta-analysis. Clin Chim Acta. 2018;484:91–98. doi:10.1016/j.cca.2018.05.01129778540
   PubMed Web of Science ®Google Scholar
• Liang C, Qi Z, Ge H, et al. Long non-coding RNA PCAT-1 in human cancers: a meta-analysis. Clin Chim Acta. 2018;480:47–55. doi:10.1016/j.cca.2018.01.04329378170
   PubMed Web of Science ®Google Scholar
• Kretz M, Webster DE, Flockhart RJ, et al. Suppression of progenitor differentiation requires the long noncoding RNA ANCR. Genes Dev. 2012;26(4):338–343. doi:10.1101/gad.195123.11222302877
   PubMed Web of Science ®Google Scholar
• Yuan SX, Wang J, Yang F, et al. Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology. 2016;63:499–511. doi:10.1002/hep.2789325964079
   PubMed Web of Science ®Google Scholar
• Mao Z, Li H, Du B, et al. LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells. Biosci Rep. 2017;37:BSR20171070. doi:10.1042/BSR2017107028951520
   PubMed Web of Science ®Google Scholar
• Li J, Zhou L. Overexpression of lncRNA DANCR positively affects progression of glioma via activating Wnt/β-catenin signaling. Biomed Pharmacother. 2018;102:602–607. doi:10.1016/j.biopha.2018.03.11629602127
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang M, Liang L, et al. Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer. Int J Clin Exp Pathol. 2015;8(9):11480.26617879
   PubMed Web of Science ®Google Scholar
• Hao YP, Qiu JH, Zhang DB, et al. Long non-coding RNA DANCR, a prognostic indicator, promotes cell growth and tumorigenicity in gastric cancer. Tumor Biol. 2017;39(6):101042831769979. doi:10.1177/1010428317699798
   Google Scholar
• Pan L, Liang W, Gu J, et al. Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells. Oncotarget. 2018;9(2):1915–1930. doi:10.18632/oncotarget.2301929416741
   PubMedGoogle Scholar
• Sha S, Yuan D, Liu Y, et al. Targeting long non-coding RNA DANCR inhibits triple negative breast cancer progression. Biol Open. 2017;6(9):bio.023135. doi:10.1242/bio.023135
   PubMed Web of Science ®Google Scholar
• Wang S, Jiang M. The long non-coding RNA-DANCR exerts oncogenic functions in non-small cell lung cancer via miR-758-3p. Biomed Pharmacother. 2018;103:94–100. doi:10.1016/j.biopha.2018.03.05329635134
   PubMed Web of Science ®Google Scholar
• Wen X, Liu X, Mao YP, et al. Long non-coding RNA DANCR stabilizes HIF-1α and promotes metastasis by interacting with NF90/NF45 complex in nasopharyngeal carcinoma. Theranostics. 2018;8(20):5676–5689. doi:10.7150/thno.2853830555573
   PubMed Web of Science ®Google Scholar
• Yang JX, Sun Y, Gao L, et al. Long non-coding RNA DANCR facilitates glioma malignancy by sponging miR-33a-5p. Neoplasma. 2018;65:790–798. doi:10.4149/neo_2018_170724N49829940760
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu Z, Wang N, et al. Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging. Exp Mol Med. 2018;50(5):57. doi:10.1038/s12276-018-0082-529717105
   PubMedGoogle Scholar
• Zhan Y, Chen Z, Li Y, et al. Long non-coding RNA DANCR promotes malignant phenotypes of bladder cancer cells by modulating the miR-149/MSI2 axis as a ceRNA. J Exp Clin Cancer Res. 2018;37(1). doi:10.1186/s13046-018-0921-1.
   Google Scholar
• Fan YH, Ji CX, Xu B, et al. Long noncoding RNA activated by TGF-β in human cancers: a meta-analysis. Clin Chim Acta. 2017;468:10–16. doi:10.1016/j.cca.2017.02.00128163033
   PubMed Web of Science ®Google Scholar
• Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med. 2012;9(5):e1001216. doi:10.1371/journal.pmed.100121622675273
   PubMed Web of Science ®Google Scholar
• Mccarthy DJ, Chen Y, Smyth GK, et al. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40(10):4288–4297. doi:10.1093/nar/gks04222287627
   PubMed Web of Science ®Google Scholar
• Dellinger TH, Smith DD, Ouyang C, et al.L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA). Gynecol Oncol. 2016;141(2):336–340. doi:10.1016/j.ygyno.2016.02.003
   Google Scholar
• Lu QC, Rui ZH, Guo ZL, et al. LncRNA-DANCR contributes to lung adenocarcinoma progression by sponging miR-496 to modulate mTOR expression. J Cell Mol Med. 2018;22(3):1527–1537. doi:10.1111/jcmm.13420
   Web of Science ®Google Scholar
• Liang H, Zhang C, Guan H, et al. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p. Cell Physiol. 2018. doi:10.1002/jcp.27484
   PubMedGoogle Scholar
• Jiang N, Wang X, Xie X, et al. lncRNA DANCR promotes tumor progression and cancer stemness features in osteosarcoma by upregulating AXL via miR-33a-5p inhibition. Cancer Lett. 2017;405:46. doi:10.1016/j.canlet.2017.06.00928642170
   PubMed Web of Science ®Google Scholar